Skip to content
  • BiotechReality JobFinder
  • Market Analysis
  • Publish on BiotechReality
  • linkedin
  • facebook
  • instagram
  • twitter
BiotechReality Home
BiotechReality – Information Intelligence System for Biopharma
  • Market Analysis
  • Healthcare & Pharmaceuticals
    • Business
    • Pharmacology
  • Clinical Trials
    • Regulatory Approval
  • Biotechnology
    • Molecular Biology
    • Genomics
    • Immunology
    • Microbiology
      • Virology
    • Diagnostic Tests
  • Science
    • Microbiology
    • Research
    • General Biology
  • Technology
    • Artificial Intelligence
  • News
    • Research
  • Newsletters
Popular
#FDA #Eli Lilly and Company #Johnson&Johnson #Clinical Data #FDA Approval #Cancer #Novo Nordisk #Quarterly Results

Tag: ARM

Artificial Intelligence Cancer Laboratory Info News

Google is developing an AI-powered augmented reality microscope for cancer detection

  • By Editor's Desk
  • 20 September 2023
Google ARM Microscope for cancer detection

Google is on their way to developing an ARM-Augmented Reality Microscope in a joint venture with the U.S. Department of Defense. Currently, Google has developed a prototype. They incorporate AI with the microscope system to classify cancer cells using visual indicators.

Tagged ARM, Cancer detection, Google, Microscope
Advertisement

Areas Covered

  • Anti-obesity Drugs
  • Artificial Intelligence
  • Astrobiology
  • Autoimmune Diseases
  • Biochemistry
  • Bioengineering
  • Bioinformatics
  • Biologics
  • Biosimilars
  • Biostatistics
  • Biotechnology
  • Blog
  • Business
  • Cancer
  • CDMO
  • Cell Biology
  • Clinical Data
  • Clinical Investigation
  • Clinical Trials
  • Collection
  • CRDMO
  • CRO
  • Cybersecurity
  • Deep Learning
  • Diabetes
  • Diagnostic Tests
  • Disease Biology
  • Diseases
  • Drug Discovery
  • Drugs
  • Engineering
  • Epidemiology
  • Gene Therapy
  • General Biology
  • Genetics
  • Genomics
  • Healthcare & Pharmaceuticals
  • Immunology
  • Immunotherapy
  • Instrumentation
  • Laboratory Info
  • Legal and Patent Affairs
  • Life Sciences
  • Machine Learning
  • Manufacturing
  • Medical Devices
  • Mental Health
  • Merger & Acquisitions
  • Microbiology
  • Microscopy
  • Molecular Biology
  • Nanotechnology
  • Neuroscience
  • News
  • Oncology
  • Pharmacology
  • Rare Diseases
  • Regenerative Medicine
  • Regulatory
  • Regulatory Approval
  • Research
  • Science
  • Science Communication
  • Supply Chain
  • Technology
  • Therapies
  • Toxicology
  • Vaccines
  • Virology
  • Weight-loss Drugs

Discover More

Novo Ozempic 2 mg MACE Analysis Shows 6% Lower Cardiovascular Risk Versus Switching to Mounjaro at EASD 2026
Research Healthcare & Pharmaceuticals News

Novo Ozempic 2 mg MACE Analysis Shows 6% Lower Cardiovascular Risk Versus Switching to Mounjaro at EASD 2026

29 September 202629 September 2026
Clinical Trials & Data Desk
AbbVie Valkai AI Partnership Deploys Purpose-Built AI Across Targeted Clinical Development Areas
Artificial Intelligence Business Healthcare & Pharmaceuticals News

AbbVie Valkai AI Partnership Deploys Purpose-Built AI Across Targeted Clinical Development Areas

29 September 202629 September 2026
BiotechReality Business Intelligence Desk
Novo HRS-1596 License: Novo Secures Hengrui Pharma’s Oral Once-Weekly GLP-1/GIP Agonist in Deal Worth Up to $2.6 Billion
Business Healthcare & Pharmaceuticals News

Novo HRS-1596 License: Novo Secures Hengrui Pharma’s Oral Once-Weekly GLP-1/GIP Agonist in Deal Worth Up to $2.6 Billion

29 September 202629 September 2026
BiotechReality Business Intelligence Desk
Merck SPR2015 KRAS G12D Inhibitor Deal Strengthens Oncology Pipeline Through $2.13 Billion Agreement
Business Healthcare & Pharmaceuticals News Research

Merck SPR2015 KRAS G12D Inhibitor Deal Strengthens Oncology Pipeline Through $2.13 Billion Agreement

28 September 202628 September 2026
BiotechReality Business Intelligence Desk
AbbVie JUVMO (Tavapadon) Wins FDA Approval as First Selective D1/D5 Receptor Agonist for Parkinson’s Disease
Regulatory Approval Clinical Data Healthcare & Pharmaceuticals News

AbbVie JUVMO (Tavapadon) Wins FDA Approval as First Selective D1/D5 Receptor Agonist for Parkinson’s Disease

28 September 202628 September 2026
Regulatory Intelligence Desk
Merck Ifinatamab Deruxtecan BLA Withdrawn in Previously Treated ES-SCLC
Clinical Data Healthcare & Pharmaceuticals News Regulatory

Merck Ifinatamab Deruxtecan BLA Withdrawn in Previously Treated ES-SCLC

27 September 202627 September 2026
Clinical Trials & Data Desk
Advertisement
BiotechReality JobFinder

  • Component Engineer – Cytiva, Bangalore
    29 September 2026
  • Manufacturing Manager – Novartis, Japan
    28 September 2026
  • Principal Application Specialist FMT APAC – Sartorius, Singapore
    27 September 2026
  • Product Manager – Sanofi, Taipei
    26 September 2026
  • Associate QA Analyst – IQVIA
    14 September 2026

BiotechReality Shots Weekly Newsletter

Processing…
Success! You're on the list.
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.
SciRealityPress BiotechReality

A SciRealityPress Associate

Contents in the website is licensed under CC BY-NC 4.0

Disclaimer: The content on this website is not meant to provide medical or any other professional advice. Understand and use the information, double check if necessary. All trademarked names mentioned in the contents belongs to their respective owners. Stock exchange data providing by Stockdio

SciRealityPress © 2026
  • About
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • Disclaimer
  • Platform Status
  • Market Analysis
  • Healthcare & Pharmaceuticals
    • Business
    • Pharmacology
  • Clinical Trials
    • Regulatory Approval
  • Biotechnology
    • Molecular Biology
    • Genomics
    • Immunology
    • Microbiology
      • Virology
    • Diagnostic Tests
  • Science
    • Microbiology
    • Research
    • General Biology
  • Technology
    • Artificial Intelligence
  • News
    • Research
  • Newsletters
  • linkedin
  • facebook
  • instagram
  • twitter